Performance analysis of CANC (Tema Oncology ETF)
Annual Return
Over the past 3 years, CANC has had an average annual return of +107.95%, outperforming the benchmark SPY, which returned +22.45% annual.
Since Sep 30, 2021, CANC has had an average annual return of -9.99%, underperforming the benchmark SPY, which returned +14.32% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +4.82% | +42.92% | -5.34% | +510.48% | -85.35% | -51.82% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +2.98% | +5.66% | -2.88% | +2.22% | +1.56% | -4.46% | +4.82% | ||||||
| 2025 | +5.69% | -0.21% | -6.07% | +3.69% | -2.77% | +1.84% | +4.75% | +2.88% | +7.71% | +7.93% | +15.39% | -2.80% | +42.92% |
| 2024 | -0.93% | +7.87% | -0.33% | -5.49% | +0.67% | +0.87% | +8.85% | +1.71% | -4.90% | -2.78% | +0.73% | -10.19% | -5.34% |
| 2023 | +20.96% | -28.10% | -27.36% | -15.47% | +75.33% | -7.72% | +38.85% | +380.64% | -7.61% | -5.00% | +9.18% | +10.48% | +510.48% |
| 2022 | -13.74% | +2.19% | -12.55% | -33.55% | -14.22% | -28.25% | -26.79% | -0.18% | -26.94% | +2.96% | -6.71% | -9.37% | -85.35% |
| 2021 | +0% | -4.55% | -42.04% | -12.91% | -51.82% |
Drawdown analysis of CANC (Tema Oncology ETF)
The maximum drawdown for the CANC was -97.53%, occurring on Apr 5, 2023. This drawdown has not yet recovered.
The current CANC drawdown is -56.54%.
Since Sep 30, 2021 CANC has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 2 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -97.53% | Oct 20, 2021 | 366 | Apr 5, 2023 | Ongoing | Ongoing | Ongoing |
| -16.18% | Oct 5, 2021 | 10 | Oct 19, 2021 | 1 | Oct 20, 2021 | 11 |